Change of opinion on the use of hydroxychloroquine for COVID-19 treatment and prevention
The use of hydroxychloroquine for COVID-19 treatment and prevention should be restricted in both out- and inpatient settings due to the lack of evidence for effectiveness and unfavorable safety profile.
Tallennettuna:
| Päätekijät: | , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Russo |
| Julkaistu: |
Izdatelstvo OKI
2020-10-01
|
| Sarja: | Качественная клиническая практика |
| Aiheet: | |
| Linkit: | https://www.clinvest.ru/jour/article/view/535 |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|